Turku, Finland

Timo Lovgren

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 126(Granted Patents)


Location History:

  • Vallaojantie, FI (1985)
  • Turku, FI (1986 - 2023)

Company Filing History:


Years Active: 1985-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Timo Lovgren: Innovator in Diagnostic Methods

Introduction

Timo Lovgren is a notable inventor based in Turku, Finland. He has made significant contributions to the field of diagnostics, particularly in relation to prostate cancer. With a total of six patents to his name, Lovgren's work has advanced the methodologies used in medical testing and analysis.

Latest Patents

Among his latest patents is a groundbreaking invention focused on compositions and methods related to the diagnosis of prostate cancer. This patent addresses improved methods for predicting whether a prostate tissue biopsy obtained from a subject will contain detectable prostate cancer. Another significant patent involves a method for stabilizing assay reagents, which includes a reagent container designed with an inner surface where at least two reagents are dried separately. This innovative design allows for the effective use of the container in various assays, including polymerase chain reaction (PCR) assays and other nucleic acid-based tests.

Career Highlights

Throughout his career, Timo Lovgren has worked with prominent companies such as Wallac Oy and Pharmacia Ab. His experience in these organizations has contributed to his expertise in the field of diagnostics and assay development.

Collaborations

Lovgren has collaborated with notable colleagues, including Ilkka Hemmila and Erkki J Soini. These partnerships have further enriched his work and innovations in the diagnostic sector.

Conclusion

Timo Lovgren's contributions to the field of diagnostics, particularly in prostate cancer detection, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical technology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…